132 related articles for article (PubMed ID: 37942542)
1. Rectal Tropism: An Extremely Rare Case of Prostate Cancer Recurrence With Metastasis to the Rectum Postradical Prostatectomy.
Trivedi A; Bathobakae L; Shenasan P; Yuridullah R; Akmal A; El-Sedfy A
J Investig Med High Impact Case Rep; 2023; 11():23247096231211053. PubMed ID: 37942542
[TBL] [Abstract][Full Text] [Related]
2. Does Early Prostate Specific Antigen Doubling Time after Radical Prostatectomy, Calculated Prior to Prostate Specific Antigen Recurrence, Correlate with Prostate Cancer Outcomes? A Report from the SEARCH Database Group.
Teeter AE; Griffin K; Howard LE; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ
J Urol; 2018 Mar; 199(3):713-718. PubMed ID: 28870860
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Rectum-Infiltrating Prostate Cancer Mimicking Prostate-Infiltrating Rectal Cancer].
Hishiki K; Takada H; Nakashima Y; Kohei N; Nishio Y; Muro H; Ohata K; Yoshimura K
Hinyokika Kiyo; 2018 Sep; 64(9):373-377. PubMed ID: 30369229
[TBL] [Abstract][Full Text] [Related]
4. Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy.
Pound CR; Christens-Barry OW; Gurganus RT; Partin AW; Walsh PC
J Urol; 1999 Oct; 162(4):1337-40. PubMed ID: 10492192
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
[TBL] [Abstract][Full Text] [Related]
6. Influence of digital rectal massage on urinary prostate-specific antigen: interest for the detection of local recurrence after radical prostatectomy.
Malavaud B; Salama G; Miédougé M; Vincent C; Rischmann P; Sarramon JP; Serre G
Prostate; 1998 Jan; 34(1):23-8. PubMed ID: 9428384
[TBL] [Abstract][Full Text] [Related]
7. Prostate specific antigen and local recurrence after radical prostatectomy.
Lightner DJ; Lange PH; Reddy PK; Moore L
J Urol; 1990 Oct; 144(4):921-6. PubMed ID: 1697917
[TBL] [Abstract][Full Text] [Related]
8. Low-dose-rate brachytherapy as salvage treatment of local prostate cancer recurrence after radical prostatectomy.
Traudt K; Ciezki J; Klein EA
Urology; 2011 Jun; 77(6):1416-9. PubMed ID: 21492918
[TBL] [Abstract][Full Text] [Related]
9. Does perineural invasion of the myenteric plexus have a key role in annular rectal invasion and digestive system symptoms of prostate carcinoma patients?
Hashimoto H; Kurata A; Nashiro T; Kuroda M; Horiuchi H
Med Hypotheses; 2015 Dec; 85(6):854-7. PubMed ID: 26433688
[TBL] [Abstract][Full Text] [Related]
10. Risk of lymph node metastases in pathological gleason score≤6 prostate adenocarcinoma: Analysis of institutional and population-based databases.
Wenger H; Weiner AB; Razmaria A; Paner GP; Eggener SE
Urol Oncol; 2017 Jan; 35(1):31.e1-31.e6. PubMed ID: 27692833
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins.
Connolly JA; Shinohara K; Presti JC; Carroll PR
Urology; 1996 Feb; 47(2):225-31. PubMed ID: 8607239
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
[TBL] [Abstract][Full Text] [Related]
13. Detection of local recurrence after radical prostatectomy by prostate specific antigen and transrectal ultrasound.
Abi-Aad AS; Macfarlane MT; Stein A; deKernion JB
J Urol; 1992 Mar; 147(3 Pt 2):952-5. PubMed ID: 1371567
[TBL] [Abstract][Full Text] [Related]
14. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
[TBL] [Abstract][Full Text] [Related]
15. Local recurrence of prostate cancer in rectal submucosa after transrectal needle biopsy and radical prostatectomy.
Vaghefi H; Magi-Galluzzi C; Klein EA
Urology; 2005 Oct; 66(4):881. PubMed ID: 16230172
[TBL] [Abstract][Full Text] [Related]
16. Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.
Patel DN; Jha S; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Chapin BF; Freedland SJ
Int J Urol; 2018 Dec; 25(12):998-1004. PubMed ID: 30253446
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.
Heidenreich A; Pfister D; Porres D
J Urol; 2015 Mar; 193(3):832-8. PubMed ID: 25254935
[TBL] [Abstract][Full Text] [Related]
18. Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.
Gugliemetti G; Sukhu R; Conca Baenas MA; Meeks J; Sjoberg DD; Eastham JA; Scardino PT; Touijer K
Actas Urol Esp; 2016 Sep; 40(7):434-9. PubMed ID: 27184342
[TBL] [Abstract][Full Text] [Related]
19. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging.
Linder BJ; Kawashima A; Woodrum DA; Tollefson MK; Karnes J; Davis BJ; Rangel LJ; King BF; Mynderse LA
Can J Urol; 2014 Jun; 21(3):7283-9. PubMed ID: 24978358
[TBL] [Abstract][Full Text] [Related]
20. Concordance of preoperative prostate endorectal MRI with subsequent prostatectomy specimen in high-risk prostate cancer patients.
Nepple KG; Rosevear HM; Stolpen AH; Brown JA; Williams RD
Urol Oncol; 2013 Jul; 31(5):601-6. PubMed ID: 21665495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
